Two recent studies from Italy reported strong effects of the PNPLA3 148M variant also on the risk of HCC in chronic hepatitis C [19], [20], while a third Italian study suggested that this allele was predominantly associated with metabolic cirrhosis [21]. Here, PNPLA3 is linked to hepatocellular carcinoma.